{"schemaVersion":1,"target":{"type":"reading","id":"72caeea6bf1be72f00106000570f5b58fce744233a487b696d2e4c4cb661a5ac","revision":"983320f9-f6a4-4eb9-8954-416af82c1e30","revisionKind":"publication-id","title":"Marginal Revolution: targeted cures create a financing dilemma","url":"https://escapemeridian.com/readings/marginal-revolution-targeted-cures-create-a-financing-dilemma-72caeea6"},"source":{"type":"source","id":"https://marginalrevolution.com/marginalrevolution/2026/11/expensive-pharmaceuticals-for-targeted-diseases.html","revision":"19f8d383c0db1a39a4fafaa2e16e3689cec188cccacb44ebc7625ae840a451eb","revisionKind":"sha256-source-text","title":"Expensive Pharmaceuticals for Targeted Diseases - Marginal REVOLUTION","url":"https://marginalrevolution.com/marginalrevolution/2026/11/expensive-pharmaceuticals-for-targeted-diseases.html"},"status":"available","items":[],"next":null,"scope":"Explicit citations in public readings and public file attachments to this reading. Shared topics are not citations. Other artifact types need an explicit reference adapter."}